1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends
Heart Pump Device Market by Product, Type, Therapy - Global Forecast to 2022

Heart Pump Device Market by Product, Type, Therapy - Global Forecast to 2022

  • May 2018
  • 132 pages
  • ID: 5398036
In this report:
The percutaneous ventricular assist device segment is expected to grow at the highest CAGR of ##.##% from 2017 to 2022.
This segment is expected to reach USD ##.## million by 2022 from USD ##.## million in 2017, at a CAGR of ##.##% from 2017 to 2022.
The total artificial heart market is expected to reach ##.## million in 2022 from ##.## million in 2017 with a CAGR of ##.##%.

Summary

Table of Contents

Search Inside

The heart pump devices market is projected to grow at a CAGR of 19.4%
The global heart pump devices market is projected to reach USD 3.98 billion by 2022 from an estimated USD 1.64 billion in 2017, at a CAGR of 19.4% during the forecast period. Rising prevalence of cardiovascular diseases, increasing number of regulatory approvals, and a huge gap between the demand and supply of donor hearts is driving the demand for heart pump devices. However, preference for alternative drug delivery modes and poor reimbursement scenario in developing countries is expected to restrain the growth of this market during the forecast period.

By product, the ventricular assist devices market is expected to grow at the highest CAGR during the forecast period (2017–2022)
Based on product, the market is segmented into ventricular assist devices, intra-aortic balloon pumps, and total artificial heart.The ventricular assist devices market is expected to grow at highest CAGR during the forecast period.

This can be attributed to improved safety and efficacy of these devices as a result of technological advancements.

By therapy, destination therapy segment is expected to grow at the highest CAGR during the forecast period
Based on therapy, the global heart pump devices market is segmented into bridge-to-transplant, bridge-to-candidacy, destination therapy, and other therapies such as bridge-to-recovery and rescue therapy. The destination therapy segment is expected to grow at the highest CAGR during the forecast period.

North America to witness the highest growth during the forecast period
North America is expected to witness the highest growth during 2017 to 2022. The highest growth rate of the North American market is attributed to rising prevalence of cardiovascular diseases, favorable reimbursement scenario, and increasing regulatory approvals in that region.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–56%, Tier 2–35% and Tier 3–9%
• By Designation – C-level–27%, Director Level–15%, Others–58%
• By Region – North America–38%, Europe–23%, Asia Pacific–25%, Row–15%

The key players in the global heart pump devices market are St. Jude Medical ( subsidiary of Abbott Laboratories) (US), Abiomed (US), Medtronic (Ireland), Getinge (Sweden), Teleflex (US), ReliantHeart (US), BerlinHeart (Germany), Terumo (Japan), SynCardia Systems (US), TandemLife (CardiacAssist) (US), Jarvik Heart (US), and Fresenius Medical Care (Germany).

Research Coverage:
The report analyzes the heart pump devices market and aims at estimating the market size and future growth potential of this market based on various segments such as product, type, therapy, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or any combination of the below mentioned five strategies.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the heart pump devices market. The report analyzes the market based on product, type, therapy, and region
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the heart pump devices market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various heart pump devices across regions
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the heart pump devices market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the heart pump devices market

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Veronica helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Neprilysin (Neutral Endopeptidase 24.11 or Atriopeptidase or Common Acute Lymphocytic Leukemia Antigen or Skin Fibroblast Elastase or Enkephalinase or CD10 or MME or EC 3.4.24.11) - Pipeline Review, H2 2018

Neprilysin (Neutral Endopeptidase 24.11 or Atriopeptidase or Common Acute Lymphocytic Leukemia Antigen or Skin Fibroblast Elastase or Enkephalinase or CD10 or MME or EC 3.4.24.11) - Pipeline Review, H2 2018

  • $ 3500
  • October 2018

Neprilysin (Neutral Endopeptidase 24.11 or Atriopeptidase or Common Acute Lymphocytic Leukemia Antigen or Skin Fibroblast Elastase or Enkephalinase or CD10 or MME or EC 3.4.24.11) - Pipeline Review, H2 ...

Aneurysm Global Clinical Trials Review, H2, 2018

Aneurysm Global Clinical Trials Review, H2, 2018

  • $ 2500
  • October 2018

Aneurysm Global Clinical Trials Review, H2, 2018SummaryGlobalData’s clinical trial report, “Aneurysm Global Clinical Trials Review, H2, 2018" provides an overview of Aneurysm clinical trials scenario.This ...

Acute Coronary Syndrome Global Clinical Trials Review, H2, 2018

Acute Coronary Syndrome Global Clinical Trials Review, H2, 2018

  • $ 2500
  • October 2018

Acute Coronary Syndrome Global Clinical Trials Review, H2, 2018SummaryGlobalData’s clinical trial report, “Acute Coronary Syndrome Global Clinical Trials Review, H2, 2018" provides an overview of Acute ...


ref:plp2018

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on